Nicholson, Robert Ian, McClelland, Richard Andrew, Gee, Julia Margaret Wendy ![]() |
Abstract
The expression of transforming growth factor-α (TGF-α) has been evaluated in 51 breast cancers of known responsiveness to endocrine therapy using immunohistochemistry. High levels of TGF-α were observed in 65% of tumors and showed no relationship with tumor estrogen receptor or epidermal growth factor receptor status or Ki67 immunostaining. TGF-α levels did, however, relate to the endocrine sensitivity of the disease, with unresponsive tumors frequently showing high levels of TGF-α immunoreactivity. This relationship was observed in estrogen receptor-positive disease and was independent of the epidermal growth factor receptor status of the tumor. No quantitative association between TGF-α and Ki67 immunostaining was observed in any of the subcategories of tumors. These data infer a role for TGF-α in the development of endocrine insensitivity in estrogen receptor-positive breast cancer by mechanisms which appear independent of tumor growth fraction, as determined by Ki67 immunostaining.
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Pharmacy Medicine |
Subjects: | R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) R Medicine > RM Therapeutics. Pharmacology |
Publisher: | American Association for Cancer Research |
ISSN: | 0008-5472 |
Last Modified: | 18 Oct 2022 14:19 |
URI: | https://orca.cardiff.ac.uk/id/eprint/17131 |
Actions (repository staff only)
![]() |
Edit Item |